# LEAP2 on Postprandial Glucose Metabolism and Food Intake

> **NCT04621409** · EARLY_PHASE1 · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Obesity

## Interventions

- **BIOLOGICAL:** Liver-enriched antimicrobial peptide 2
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04621409
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-17
- **Primary completion:** 2021-02-18
- **Final completion:** 2021-02-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621409, "LEAP2 on Postprandial Glucose Metabolism and Food Intake". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04621409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*